| 000 | 01656 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516164028.0 | ||
| 264 | 0 | _c20140113 | |
| 008 | 201401s 0 0 eng d | ||
| 022 | _a1532-6535 | ||
| 024 | 7 |
_a10.1038/clpt.2013.161 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCarr, D F | |
| 245 | 0 | 0 |
_aSLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice research datalink. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _cDec 2013 |
||
| 300 |
_a695-701 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCreatine Kinase _xblood |
| 650 | 0 | 4 | _aDatabases, Factual |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGeneral Practice |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aLiver-Specific Organic Anion Transporter 1 |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMuscular Diseases _xchemically induced |
| 650 | 0 | 4 |
_aOrganic Anion Transporters _xgenetics |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 |
_aUbiquinone _xgenetics |
| 650 | 0 | 4 | _aUnited Kingdom |
| 700 | 1 | _aO'Meara, H | |
| 700 | 1 | _aJorgensen, A L | |
| 700 | 1 | _aCampbell, J | |
| 700 | 1 | _aHobbs, M | |
| 700 | 1 | _aMcCann, G | |
| 700 | 1 | _avan Staa, T | |
| 700 | 1 | _aPirmohamed, M | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 94 _gno. 6 _gp. 695-701 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/clpt.2013.161 _zAvailable from publisher's website |
| 999 |
_c23001192 _d23001192 |
||